Personalized Cancer Vaccine in Egyptian Cancer Patients

Summary

Evaluate safety and immunogenicity of peptide cancer vaccine in patients with hepatocellular carcinoma (HCC) who developed recurrence after surgical resection and refractory to the available institutional standard of care lines of treatment .

Timeline

Start

2021-04-19

Primary completion

2024-04

Completion

2024-08

Drugs

Indications